Presentations & Posters
POSTER: Tuneable
suppression of
VSV-G toxicity for the generation of stable lentiviral vector producer cell lines
ASGCT, BOSTON
MAY 11-15, 2026
Poster by
Nahid Zareian
Senior Scientist, Innovation
Glenda J. Dickson, PhD
Senior Principal Scientist, Innovation
Developing systems for in vivo delivery of lentiviral vectors
ISCT, DUBLIN
MAY 6-9, 2026
Glenda J. Dickson, PhD
Senior Principal Scientist, Innovation
Nicholas Ostrout, PhD
VP Commercial Development and Corporate Strategy
Farzin Farzaneh, PhD
Chief Scientific Officer
Rethinking lentiviral stable producer cell lines: To VSV or not to VSV, that is the question
ASGCT, New Orleans
May 13-17, 2025
Presented by
Glenda J. Dickson, PhD
Senior Principal Scientist, Innovation
Serum Free Suspension HEK293 Cells Stably Expressing Gag/Pol, Rev, VSV-G for Efficient Production of Lentiviral Vectors
ASGCT, New Orleans
May 13-17, 2025
Presented by
Glenda J. Dickson, PhD
Senior Principal Scientist, Innovation
POSTER
: Lentiviral Vectors Displaying Ligands for Enhanced Capture, Purification, Concentration and Targeted Infection of Specifically Selected Cells
ASGCT, New Orleans
May 13-17, 2025
Presented by
Glenda J. Dickson, PhD
Senior Principal Scientist, Innovation
Panobinostat for Improved LVV Production Versus Other HDAC Inhibitors
ISCT, New Orleans
May 7-10, 2025
Presented by
Zakeria Abdi, MSc
Senior Scientist, Innovation